News Stories

May, 2019

MIAMI, Fla. – (May 16, 2019) – The NLA has released a statement paper that provides updated guidance to clinicians to help identify patient groups in whom treatment with PCSK9 monoclonal antibodies (mAbs) provides a reasonable value. 

0
No votes yet
Name: Top Stories
Apr, 2019

The NLA will be holding the following business meetings at the NLA Scientific Sessions in Miami, FL on May 16-19, 2019. Business meetings will take place on the general session stage and will include presentations of officer slates:

Northeast Lipid Association (NELA) Business Meeting

Friday, May 17, 2019 from 8:55 – 9:00 AM ET

 

Southwest Lipid Association (SWLA) Business Meeting

Friday, May 17, 2019 from 4:30 – 4:35 PM ET

 

Pacific Lipid Association (PLA) Business Meeting

0
No votes yet
Name: Top Stories
Apr, 2019

JACKSONVILLE, Fla. (April 12, 2019) — The 2019 National Lipid Association Nominating Committee released its annual report and recommendations on Monday.

0
No votes yet
Name: Top Stories